MOLINA HEALTHCARE, INC.
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 4 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Oct 23, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 23, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Oct 23, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Jul 28, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 24, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 24, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Jul 24, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Jul 14, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Jul 14, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 13, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 9, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Jul 9, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Jun 23, 2026 | RBC Capital | initiate | — → Sector Perform | — | 55% |
| Jun 8, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Jun 4, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 26, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| May 22, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 11, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| May 11, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| May 11, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 27, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 27, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Apr 24, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 24, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Apr 24, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 12, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Mar 12, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 4, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 20, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | $141 | 54% |
| Feb 17, 2026 | Truist Securities | maintain | Hold → Hold | $145 | 54% |
| Feb 12, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $124 | 54% |
| Feb 10, 2026 | Barclays | maintain | Underweight → Underweight | $133 | 53% |
| Feb 9, 2026 | TD Cowen | maintain | Hold → Hold | $144 | 54% |
| Feb 9, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | $144 | 50% |
| Jan 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | $208 | 54% |
| Jan 5, 2026 | Barclays | maintain | Underweight → Underweight | $164 | 53% |
| Nov 12, 2025 | Wells Fargo | maintain | Overweight → Overweight | $165 | 54% |
| Oct 24, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $167 | 54% |
| Oct 24, 2025 | UBS | maintain | Neutral → Neutral | $170 | 54% |
| Oct 24, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $180 | 50% |
| Oct 24, 2025 | Barclays | downgrade | Equal-Weight → Underweight | $144 | 53% |
| Oct 14, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $204 | 54% |
| Oct 14, 2025 | Goldman Sachs | initiate | — → Neutral | $207 | 54% |
| Oct 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $231 | 54% |
| Sep 5, 2025 | Bernstein | maintain | Outperform → Outperform | $220 | 52% |
| Sep 4, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $185 | 53% |
| Aug 26, 2025 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $210 | 50% |
| Aug 15, 2025 | Wells Fargo | maintain | Overweight → Overweight | $198 | 54% |
| Jul 29, 2025 | JP Morgan | maintain | Neutral → Neutral | $184 | 55% |
No cross-platform signals in the last 90 days